Drew C. Deniger

Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor

Jared Gartner, Bryan Howie, Daniel C Douek, 2016, Cancer Immunology Research.

Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers

J. Gartner, V. Hill, S. Rosenberg, 2019, The Journal of clinical investigation.

T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

J. Gartner, S. Rosenberg, T. Prickett, 2018, Clinical Cancer Research.

Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy

Neville E. Sanjana, N. Sanjana, K. Wood, 2019, bioRxiv.

Adoptive cell therapy targeting common p53 neoantigens in human solid cancers

Chuong D. Hoang, C. Hoang, J. Gartner, 2021 .

Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells

Sri Krishna, S. Rosenberg, Frank J. Lowery, 2020, Journal of immunotherapy.

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

J. Gartner, S. Rosenberg, T. Prickett, 2019, Nature Communications.

Cancer genes disfavoring T cell immunity identified via integrated systems approach

Roxana A. Stefanescu, Neville E. Sanjana, N. Sanjana, 2022, Cell reports.